Clonidine Reduces Nociceptive Responses in Mouse Orofacial Formalin Model: Potentiation by Sigma-1 Receptor Antagonist BD1047 without Impaired Motor Coordination

Biological & Pharmaceutical Bulletin
Seo-Yeon YoonDae-Hyun Roh

Abstract

Although the administration of clonidine, an alpha-2 adrenoceptor agonist, significantly attenuates nociception and hyperalgesia in several pain models, clinical trials of clonidine are limited by its side effects such as drowsiness, hypotension and sedation. Recently, we determined that the sigma-1 receptor antagonist BD1047 dose-dependently reduced nociceptive responses in a mouse orofacial formalin model. Here we examined whether intraperitoneal injection of clonidine suppressed the nociceptive responses in the orofacial formalin test, and whether co-administration with BD1047 enhances lower-dose clonidine-induced anti-nociceptive effects without the disruption of motor coordination and blood pressure. Formalin (5%, 10 µL) was subcutaneously injected into the right upper lip, and the rubbing responses with the ipsilateral fore- or hind-paw were counted for 45 min. Clonidine (10, 30 or 100 µg/kg) was intraperitoneally administered 30 min before formalin injection. Clonidine alone dose-dependently reduced nociceptive responses in both the first and second phases. Co-localization for alpha-2A adrenoceptors and sigma-1 receptors was determined in trigeminal ganglion cells. Interestingly, the sub-effective dose of BD1047 (3 mg/kg...Continue Reading

References

Nov 1, 1990·Anesthesiology·R MendezK Kashtan
Apr 1, 1984·The Journal of Physiology·R A North, M Yoshimura
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·M HannerH Glossmann
Jun 3, 2004·Neuroscience and Biobehavioral Reviews·Patrick Raboisson, Radhouane Dallel
Jun 16, 2004·Psychopharmacology·Xavier GuitartXavier Monroy
Dec 13, 2006·The Journal of Pain : Official Journal of the American Pain Society·Philippe LuccariniRadhouane Dallel
Feb 20, 2007·British Journal of Anaesthesia·M WolffA Olschewski
Jan 27, 2009·Pharmacology, Biochemistry, and Behavior·H F MirandaJ C Prieto
Feb 4, 2010·Inflammopharmacology·J MuñozH F Miranda
Sep 28, 2010·Trends in Pharmacological Sciences·Tsung-Ping SuArnold E Ruoho

❮ Previous
Next ❯

Citations

Jan 19, 2019·British Journal of Pharmacology·Zahra Bahari, Gholam Hossein Meftahi
Aug 3, 2021·Intensive Care Medicine Experimental·Temitayo O IdowuSascha David

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.